Krop
David Christian Johannes Krop, Heerlen NL
Patent application number | Description | Published |
---|---|---|
20140285034 | Linear motor with contactless energy transfer - An integrated electromagnetic energy conversions device is provided that includes a synchronous or brushless linear (SoBL) motor, and a transformer, where the transformer is integrated electromagnetically and topologically with the SoBL motor, where an electromagnetic field orientation of the transformer is perpendicular to an electromagnetic field orientation of the SoBL motor, where a magnetic-field decoupling between the SoBL motor and the transformer is provided and a position independent magnetic coupling of the transformer is provided, where the integrated SoBL motor and the transformer operate simultaneously in a motor and transformer mode. | 09-25-2014 |
Ian Krop, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20100273158 | HIN-1, A Tumor Suppressor Gene - The invention encompasses isolated DNAs encoding HIN-1 polypeptides, vectors containing such DNAs, cells containing the vectors, and isolated HIN-1 polypeptides. The invention also features methods of making and using HIN-1 polypeptides. | 10-28-2010 |
Julie Krop, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20110224138 | METHODS FOR TREATING PAIN INDUCED BY INJURIES AND DISEASES OF AN ARTICULAR JOINT - Described herein are methods for using bone morphogenetic proteins (BMPs), such as OP-1 (also known as BMP-7), to treat pain caused by osteoarthritis. The methods involve administering to a patient suffering from pain caused by osteoarthritis a BMP, for example, intraarticularly by injection directly into the joint afflicted with osteoarthritis. The methods of the invention provide long-term pain relief to sufferers of osteoarthritis and can improve the functionality of the joint to which the BMP is administered. | 09-15-2011 |
20140303113 | HEPATITIS C VIRAL INFECTION TREATMENT USING A COMBINATION OF COMPOUNDS - Described herein is a combination that includes compound (A) and compound (B), or a pharmaceutically acceptable salt of the foregoing, for ameliorating and/or treating a hepatitis C viral infection. | 10-09-2014 |